1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsBiological Technologies Broad Agency Announcement (BAA) HR001124S0034 is sponsored by Defense Advanced Research Projects Agency (DARPA). Seeks innovative proposals that push the boundaries of biotechnology, impacting defense, medicine, materials science, and beyond, with an emphasis on breakthrough technologies that support warfighters and improve healthcare and biosafety.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
DARPA Broad Agency Announcement (BAA) for Biological Technologies - EverGlade DARPA Broad Agency Announcement (BAA) for Biological Technologies The Defense Advanced Research Projects Agency (DARPA) has issued a Broad Agency Announcement (BAA) for Biological Technologies (HR001124S0034) under its Biological Technologies Office (BTO). This initiative aims to leverage biology’s unique properties to enhance national security.
DARPA is seeking innovative proposals that push the boundaries of biotechnology, impacting defense, medicine, materials science, and beyond.
Broad Agency Announcement Biological Technologies - HR001124S0034 The Scope of DARPA’s Biological Technologies Initiative The BAA invites proposals in a wide range of biotechnological research areas, emphasizing breakthrough technologies that support warfighters and improve healthcare and biosafety.
Submissions are encouraged in areas that align with DARPA’s national security mission, including machine learning (ML) and artificial intelligence (AI) , human performance optimization, advanced materials, environmental systems, biosecurity, and biomedical and biodefense technologies. 1.
Machine Learning (ML) & Artificial Intelligence (AI) Groundbreaking ML/AI innovations that advance biological models and enhance warfighter decision-making by: Integrating biological data into foundational models to exceed state-of-the-art performance. Accelerating biological system simulations from the subcellular level to the organismal and environmental levels.
Developing ML/AI tools to improve decision-making and predict human performance in complex environments. 2. Human Performance Optimization Multidisciplinary solutions that optimize human performance and resilience by: Enhance neurological health, manage fatigue, cognition, and teamwork in extreme conditions.
Leverage biotechnology, neuroscience, and psychology interventions to boost human performance. Develop technologies for continuous monitoring and integration to boost readiness and performance. 3.
Bio-Inspired Materials, Sensors, and Processing Innovations that integrate novel materials, predictive modeling, and advance sensor platforms to revolutionize system engineering and performance by: Developing bio-inspired materials, sensors, processes with scalable predictive tools. Creating platforms that are fusing biological principles with engineered systems.
Engineering compact sensors with low SWaP, high performance, and remote detection. 4. Environmental & Ecosystem Technologies Projects that secure resources, defend ecosystems, and restore environmental balance by: Using biotechnology to mitigate threats to food and water supplies.
Developing and leveraging insights from non-human biology for tactical, operational advantages. Bioengineering solutions for cleanup, restoration, and sequestration. 5.
Biosecurity & Biosafety Solutions that can safeguard biological data, prevent pathogen threats, and enhance infectious disease detection and response by: Developing technologies and approaches that can ensure biosafety and biosecurity of biological hardware, data, and AI. Advancing tools that can characterize emerging pathogens to prevent spread and determine origin.
Creating technologies to treat, prevent, forecast, and detect infectious diseases that threaten health, economy, and society. 6. Biomedical & Biodefense Innovations Biotechnological innovations that can protect warfighter health and strengthen biodefense by: Developing rapid manufacturing and resilient distribution of critical therapeutics.
Creating next-generation cellular therapies and controlled delivery platforms. Advancing diagnostics, prophylactics, and therapeutics for austere environments. Submission & Funding Details Rolling submissions: Abstracts and full proposals are accepted until September 10, 2025, at 4PM ET.
Multiple awards are anticipated, including procurement contracts, cooperative agreements, and other transactions. Evaluation criteria: Scientific merit, relevance to DARPA’s mission, and cost realism If your company has considered applying for DARPA funding , your federal funding journey starts here. EverGlade is a national firm that helps organizations win and manage federal awards.
We offer services ranging from Pursuit, Proposal and Post-Award support to comply with federal regulations at agencies including BARDA, ASPR, NIH, DTRA, JPEO, DOD, DIU, DOE, and DARPA . Collaborate with EverGlade We partner with life sciences and technology innovators to secure and execute funding for high-risk, high-impact programs across the federal and commercial sectors.
Prev Previous Navigating Emerging Trends in Federal Funding for AI & Technology Next Maximizing Federal-Private Partnerships for Innovation Next Sign-up for EverGlade Alerts Building the $20M Quantum Factory: What NIST’s New Manufacturing Center Means for Innovators BARDA’s RFI Explores Repurposing Autoinjector Equipment for New Drug Delivery Devices BARDA Issues RFI on Adjuvanted Egg-Based Influenza Vaccine for Pandemic Preparedness The Escalating Bundibugyo Ebola Outbreak and the $1.
4 Billion Push for Biodefense Funding DOE Sets 2028 Deadline for Fault-Tolerance Quantum Computing Under New Genesis Mission The End of Mega Labs? What the Proposed NIH Grant Cap Means for Universities Leave a Comment Cancel Reply Your email address will not be published. Required fields are marked * Save my name, email, and website in this browser for the next time I comment.
According to the current listing, eligibility includes: Proposals are invited from a wide range of biotechnological research areas. Submissions are encouraged in areas that align with DARPA's national security mission. Confirm the full requirements in the official notice before applying.
Biological Technologies Broad Agency Announcement (BAA) HR001124S0034 is funded by Defense Advanced Research Projects Agency (DARPA). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
DPA26BZ06-DV023 is a Direct-to-Phase-II SBIR paying $700,000 over 18 months plus a $500,000 option. The physics demands 256x more transmit power than the systems that qualify you to compete, and DARPA will not accept modeling alone as proof. Here is the eligibility wall, the five engineering problems, and who can realistically win it before the October 21 close.
Read articleRelease 6's SBIR topics got the attention. Its three STTR topics — SHIELDER, fuel-flexible electric propulsion, and hypersonic wind tunnel noise diagnostics — are all Direct-to-Phase-II, all require a research institution to perform at least 30 percent of the work, and all close October 21, 2026. The feasibility gates are the real filter.
Read articleDPA26BZ06-DV026 offers $300,000 at Phase I or $1,800,000 as a single Direct-to-Phase-II tranche with no options. The deliverable is a simulated auction market that measures whether AI agents deceive, collude, or manipulate the humans they serve — measured entirely from the outside. Here is the 90% efficiency gate, the team composition most bidders will get wrong, and why this topic sits in DARPA's biology office.
Read article